Metabolic and intestinal effects of short-chain fatty acids.
Current research has identified the metabolic and intestinal effects of SCFA in experimental models and humans. Ample physiologic rationale has come forth to justify controlled studies of the administration of SCFA in selected patients with intestinal dysfunction.
Rombeau
J L
JL
Department of Surgery, University of Pennsylvania, Philadelphia.
Kripke
S A
SA
D000818:Animals; D050260:Carbohydrate Metabolism; D005232:Fatty Acids, Volatile / Q000378:metabolism*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D008322:Mammals / Q000378:metabolism*
D005232:Fatty Acids, Volatile